palmidrol has been researched along with Nerve Pain in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 17 (65.38) | 24.3611 |
| 2020's | 7 (26.92) | 2.80 |
| Authors | Studies |
|---|---|
| Avagliano, C; Calignano, A; Cristiano, C; Cuozzo, M; Liguori, FM; Russo, R | 1 |
| Pickering, E; Rao, A; Steadman, KJ; Steels, EL; Vitetta, L | 1 |
| Bartolucci, G; Ciampi, C; Di Cesare Mannelli, L; Ferrara, V; Ghelardini, C; Lucarini, E; Micheli, L; Nobili, S; Pallecchi, M; Toti, A | 1 |
| Kiso, T; Sekizawa, T; Watabiki, T | 1 |
| Cuzzocrea, S; D'Amico, R; Di Paola, R; Impellizzeri, D | 1 |
| Borrelli, R; Ditto, MC; Fusaro, E; Parisi, S | 1 |
| Kamper, D | 1 |
| Chirchiglia, D; Cione, E; Gallelli, L; Paventi, S; Seminara, P | 1 |
| Belardo, C; Boccella, S; Iannotta, M; Maione, S; Marabese, I; Mazzitelli, M; Neugebauer, V; Palazzo, E; Pieretti, G | 1 |
| Cruccu, G; Marchettini, P; Stefano, GD; Truini, A | 1 |
| Cristino, L; De Petrocellis, L; Di Marzo, V; Korostynski, M; Makuch, W; Malek, N; Petrosino, S; Przewlocka, B; Slezak, M; Starowicz, K; Zychowska, M | 1 |
| Costa, B; Della Valle, MF; Facci, L; Fusco, M; Giusti, P; Skaper, SD; Zusso, M | 1 |
| Burlakova, N; Coicou, L; Khasabova, IA; Lewandowski, CT; Lindberg, AE; Paz, J; Seybold, VS; Simone, DA; Yao, X | 1 |
| Jaen, A; Morera, C; Sabates, S | 1 |
| Boccella, S; Calignano, A; Corti, F; Cuzzocrea, S; Di Cesare Mannelli, L; Esposito, E; Ghelardini, C; Luongo, L; Maione, S; Pacini, A | 1 |
| Belardo, C; D'Aniello, A; de Bartolomeis, A; De Gregorio, D; de Novellis, V; Di Marzo, V; Guida, F; Iannotta, M; Lattanzi, R; Luongo, L; Maione, S; Marabese, I; Marmo, F; Napolitano, F; Piscitelli, F; Romano, R; Rossi, F; Usiello, A | 1 |
| Andresen, SR; Bach, FW; Biering-Sørensen, F; Bing, J; Finnerup, NB; Hagen, EM; Hansen, RM; Johannesen, IL; Nielsen, JF; Rice, ASC | 1 |
| Apodaca, RL; Breitenbucher, JG; Brown, SM; Chang, L; Chaplan, SR; Karbarz, MJ; Keith, JM; Luo, L; Palmer, JA; Scott, BP; Tham, CS; Webb, M; Wennerholm, ML; Wilson, SJ; Wu, J | 1 |
| Alexander, SP; Barrett, D; Chapman, V; Eldeeb, K; Elphick, MR; Guasti, L; Jhaveri, M; Kendall, D; Michael, GJ; Richardson, D | 1 |
| Bramanti, P; Calabrò, RS; Gervasi, G; Marino, S; Mondo, PN | 1 |
| Hesselink, JM; Kopsky, DJ | 2 |
| Przewlocka, B; Starowicz, K | 1 |
| Facci, L; Skaper, SD | 1 |
| Bettoni, I; Bonfanti, P; Colombo, A; Comelli, F; Costa, B | 1 |
| Bellini, G; Boccella, S; de Novellis, V; Gatta, L; Guida, F; Luongo, L; Maione, S; Rossi, F | 1 |
4 review(s) available for palmidrol and Nerve Pain
| Article | Year |
|---|---|
ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.
Topics: Amides; Analgesics; Anti-Inflammatory Agents; Ethanolamines; Humans; Neuralgia; Palmitic Acids | 2020 |
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.
Topics: Amides; Animals; Endocannabinoids; Ethanolamines; Humans; Inflammation; Mast Cells; Neuralgia; Neuroglia; Pain Management; Palmitic Acids | 2014 |
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.
Topics: Amides; Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; Behavior; Benzamides; Carbamates; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Glycerides; Humans; Microglia; Neuralgia; Palmitic Acids; Peripheral Nerve Injuries; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Spinal Cord Injuries; TRPV Cation Channels | 2012 |
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.
Topics: Amides; Animals; Cell Communication; Central Nervous System; Endocannabinoids; Ethanolamines; Humans; Inflammation; Inflammation Mediators; Mast Cells; Neuralgia; Neurodegenerative Diseases; Neuroglia; Neuroprotective Agents; Palmitic Acids; Synaptic Transmission | 2012 |
4 trial(s) available for palmidrol and Nerve Pain
| Article | Year |
|---|---|
A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.
Topics: Australia; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Inflammation; Neuralgia; Treatment Outcome | 2022 |
N-Palmitoyl Ethanol Amide Pharmacological Treatment in Patients With Nonsurgical Lumbar Radiculopathy.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Amides; Codeine; Drug Combinations; Ethanolamines; Female; Humans; Lumbar Vertebrae; Male; Middle Aged; Neuralgia; Palmitic Acids; Prospective Studies; Radiculopathy; Single-Blind Method | 2018 |
Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain - Sciatica.
Topics: Adult; Amides; Cohort Studies; Ethanolamines; Female; Humans; Low Back Pain; Male; Middle Aged; Neuralgia; Pain Measurement; Palmitic Acids; Sciatica; Surveys and Questionnaires | 2019 |
Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Amides; Analgesics; Analysis of Variance; Double-Blind Method; Ethanolamines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuralgia; Palmitic Acids; Spinal Cord Injuries; Treatment Outcome | 2016 |
18 other study(ies) available for palmidrol and Nerve Pain
| Article | Year |
|---|---|
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice.
Topics: Amides; Animals; Endocannabinoids; Ethanolamines; Mice; Neuralgia; Paclitaxel; Palmitic Acids; PPAR alpha | 2022 |
Ultramicronized
Topics: Analgesics, Opioid; Animals; Histamine; Mast Cells; Morphine; Neuralgia; Neuroglia; Rats | 2024 |
ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
Topics: Amides; Amidohydrolases; Analgesics; Animals; Behavior, Animal; Brain; Chronic Pain; Disease Models, Animal; Enzyme Inhibitors; Ethanolamines; Male; Neuralgia; Oleic Acids; Pain Threshold; Palmitic Acids; Piperidines; Pyridines; Rats, Sprague-Dawley | 2020 |
Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
Topics: Acetylcarnitine; Aged; Amides; Analgesics, Non-Narcotic; Carpal Tunnel Syndrome; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Humans; Lower Extremity; Male; Middle Aged; Neuralgia; Palmitic Acids; Peripheral Nervous System Diseases; Rheumatic Diseases; Sciatic Neuropathy | 2021 |
Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study.
Topics: Aged; Amides; Ethanolamines; Herpes Zoster; Humans; Male; Neuralgia; Palmitic Acids; Pisum sativum; Quality of Life | 2022 |
Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain.
Topics: Amides; Animals; Dentate Gyrus; Disease Models, Animal; Ethanolamines; Excitatory Postsynaptic Potentials; Humans; Long-Term Potentiation; Male; Memory; Mice; Neuralgia; Olfactory Cortex; Palmitic Acids; Peripheral Nerve Injuries; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2019 |
Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Topics: Amides; Amidohydrolases; Analgesia; Animals; Arachidonate 15-Lipoxygenase; Arachidonic Acids; Benzamides; Calcium Signaling; Carbamates; Diterpenes; Endocannabinoids; Ethanolamines; Flavanones; Glycerides; HEK293 Cells; Humans; Hyperalgesia; Injections, Spinal; Lipoxygenase Inhibitors; Male; Neuralgia; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Posterior Horn Cells; Rats; Rats, Wistar; Sciatic Nerve; Spinal Cord; TRPV Cation Channels | 2013 |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Topics: Amides; Analgesics; Animals; Antineoplastic Agents; Arachidonic Acids; Benzodioxoles; Cells, Cultured; Cisplatin; Disease Models, Animal; Endocannabinoids; Ethanolamines; Ganglia, Spinal; Glycerides; Hyperalgesia; Indoles; Male; Mesencephalon; Mice; Mice, Inbred C3H; Monoacylglycerol Lipases; Morpholines; Neuralgia; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Skin; Spinal Cord | 2014 |
Sex differences in N-palmitoylethanolamide effectiveness in neuropathic pain associated with lumbosciatalgia.
Topics: Adult; Aged; Amides; Analgesics; Ethanolamines; Female; Humans; Low Back Pain; Lumbosacral Region; Male; Middle Aged; Neuralgia; Palmitic Acids; Sex Factors; Treatment Outcome; Young Adult | 2015 |
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.
Topics: Activating Transcription Factor 3; Amides; Animals; Behavior, Animal; Disease Models, Animal; Ethanolamines; Ganglia, Spinal; HT29 Cells; Humans; Inflammation Mediators; Male; Nervous System; Neuralgia; Neuroglia; Neurons; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Palmitic Acids; Rats, Sprague-Dawley | 2015 |
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice.
Topics: Amides; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cells, Cultured; Electrophysiological Phenomena; Ethanolamines; Glutamic Acid; Homeostasis; Immobilization; Male; Mice; Microglia; Microinjections; Neuralgia; Neurons; Palmitic Acids; Prefrontal Cortex; Proto-Oncogene Proteins c-akt; Receptor, trkB; Signal Transduction; Synapses; Tail | 2015 |
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Topics: Amides; Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Brain; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Hot Temperature; Humans; Hydrolysis; Isoenzymes; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuralgia; Oleic Acids; Pain; Pain Measurement; Pain Threshold; Palmitic Acids; Piperazines; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reaction Time; Recombinant Proteins; Thiadiazoles | 2009 |
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.
Topics: Amides; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cell Proliferation; Disease Models, Animal; Endocannabinoids; Ethanolamines; Glycerides; Microglia; Minocycline; Neuralgia; Palmitic Acids; Polyunsaturated Alkamides; Rats; Spinal Cord | 2009 |
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide.
Topics: Adult; Amides; Analgesics; Animals; Diagnostic Errors; Endocannabinoids; Ethanolamines; Humans; Male; Nerve Compression Syndromes; Neuralgia; Palmitic Acids; Pelvic Pain; Perineum; Treatment Outcome | 2010 |
Nerve regeneration in neuropathic pain.
Topics: Acetylcarnitine; Amides; Endocannabinoids; Ethanolamines; Humans; Nerve Regeneration; Neuralgia; Nootropic Agents; Palmitic Acids | 2010 |
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.
Topics: Acupuncture Therapy; Amides; Analgesia; Analgesics; Chronic Disease; Endocannabinoids; Ethanolamines; Female; Humans; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Management; Palmitic Acids; Peroxisome Proliferator-Activated Receptors; PPAR alpha | 2012 |
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.
Topics: Amides; Analgesics; Animals; Endocannabinoids; Ethanolamines; Male; Mast Cells; Mice; Mice, Inbred C57BL; Neuralgia; Pain Measurement; Palmitic Acids; Treatment Outcome | 2013 |
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.
Topics: Action Potentials; Amides; Animals; Endocannabinoids; Ethanolamines; Formaldehyde; Male; Mice; Mice, Inbred ICR; Microglia; Neuralgia; Neuroglia; Pain Measurement; Palmitic Acids; Phenotype; Spinal Cord | 2013 |